Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Trends Neurosci. 2022 Mar 28;45(5):384–400. doi: 10.1016/j.tins.2022.03.001

Table 1.

A summary of studies using Cre/loxP system to probe physiological roles of InsR signaling in different brain cell types

Name Cell-type of interests Cre-driver Main findings of the InsR KO phenotypes Physiological importance Refs
NIRKO brain-specific Nestin-Cre
  • increased food intake in females;

  • mild insulin resistance and dyslipidemia;

  • hypothalamic hypogonadism;

  • loss of insulin stimulated PIP3 signaling

  • Tau hyperphosphorylation;

  • attenuated phosphorylated hepatic STAT3;

  • impaired GLUT4 translocation;

  • brain mitochondrial dysfunction;

  • dopaminergic dysfunction;

  • late-age onset-related anxiety- and depression-like behaviors

Regulation of energy disposal, fuel metabolism, reproduction, brain-liver crosstalk, glucose sensing, brain cholesterol metabolism, mitochondrial function, and dopamine signaling [5, 6, 4244, 107, 142]
GIRKO Astrocyte-specific GFAP-Cre, GFAP-CreERT2, GLAST-CreERT2
  • impaired responses to changes in glucose availability;

  • decreased ATP release from astrocytes;

  • anxiety- and depression-like behaviors;

  • longer and irregular estrus cycles;

  • decreased pregnancy rates and reduced litter sizes;

  • dysregulation of the HPG axis

hypothalamic glucose sensing, regulation of systemic glucose metabolism, dopaminergic signaling, ATP exocytosis, HPG axis [7, 62, 143]
EndoIRKO Vascular endothelial cells-specific Cdh5-Cre Slcolc1-CreERT2
  • delayed onset of insulin signaling in the brain;

  • decreased levels of hypothalamic POMC, increased food intake and obesity;

  • delayed acute hypoglycemic effect of systemic insulin administration and impaired glucose tolerance;

  • Not necessary to maintain insulin sensitivity

Transendothelial insulin delivery; kinetics of insulin signaling [74, 77, 79]